Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
出版年份 2019 全文链接
标题
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
作者
关键词
-
出版物
Cancers
Volume 11, Issue 12, Pages 1878
出版商
MDPI AG
发表日期
2019-11-27
DOI
10.3390/cancers11121878
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting Receptor Kinases in Colorectal Cancer
- (2019) Marilina García-Aranda et al. Cancers
- Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
- (2019) Patrycja Nowak-Sliwinska et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- LBA-006BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E–mutant metastatic colorectal cancer
- (2019) S Kopetz et al. ANNALS OF ONCOLOGY
- Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression
- (2019) Robert H. Berndsen et al. BRITISH JOURNAL OF CANCER
- Consensus guidelines for the use and interpretation of angiogenesis assays
- (2018) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Beyond mouse cancer models: Three-dimensional human-relevant in vitro and non-mammalian in vivo models for photodynamic therapy
- (2017) Malgorzata Kucinska et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- ProteomicsDB
- (2017) Tobias Schmidt et al. NUCLEIC ACIDS RESEARCH
- BRAFMutations as Predictive Biomarker for Response to Anti‐EGFR Monoclonal Antibodies
- (2017) Emilie M. J. van Brummelen et al. ONCOLOGIST
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- The Challenges of Colorectal Cancer Survivorship
- (2017) Crystal S. Denlinger et al. Journal of the National Comprehensive Cancer Network
- A new algorithm for a better characterization and timing of the anti-VEGF vascular effect named “normalization”
- (2016) Karima El Alaoui-Lasmaili et al. ANGIOGENESIS
- Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer
- (2016) Samira Jaeger et al. CANCER RESEARCH
- Role of the tumor stroma in resistance to anti-angiogenic therapy
- (2016) Elisabeth J.M. Huijbers et al. DRUG RESISTANCE UPDATES
- Sunitinib activates Axl signaling in renal cell cancer
- (2016) Johannes C. van der Mijn et al. INTERNATIONAL JOURNAL OF CANCER
- Optimization of drug combinations using Feedback System Control
- (2016) Patrycja Nowak-Sliwinska et al. Nature Protocols
- Combine and conquer: challenges for targeted therapy combinations in early phase trials
- (2016) Juanita S. Lopez et al. Nature Reviews Clinical Oncology
- Recommendations from the INHAND Apoptosis/Necrosis Working Group
- (2016) Susan A. Elmore et al. TOXICOLOGIC PATHOLOGY
- Current targeted therapies in the treatment of advanced colorectal cancer: a review
- (2016) Andrew Moriarity et al. Therapeutic Advances in Medical Oncology
- Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
- (2015) Andrea Weiss et al. ANGIOGENESIS
- Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy
- (2015) Andrea Weiss et al. Scientific Reports
- Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction
- (2015) Esther A. Kleibeuker et al. Cancer Medicine
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- A streamlined search technology for identification of synergistic drug combinations
- (2015) Andrea Weiss et al. Scientific Reports
- The chicken chorioallantoic membrane model in biology, medicine and bioengineering
- (2014) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
- (2014) T. Troiani et al. CLINICAL CANCER RESEARCH
- Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization
- (2014) Andrea Weiss et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
- (2012) A. W. Griffioen et al. CLINICAL CANCER RESEARCH
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML
- (2012) Georg E Winter et al. Nature Chemical Biology
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrinsic caspase-8 activation mediates sensitization of erlotinib-resistant tumor cells to erlotinib/cell-cycle inhibitors combination treatment
- (2012) M Orzáez et al. Cell Death & Disease
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems
- (2009) M. Cecilia Subauste et al. CLINICAL & EXPERIMENTAL METASTASIS
- Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm
- (2008) Pak Kin Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now